Biotechnology
Swiss companies operating in the same biotechnology industry
The table below has Swiss companies that operate under the same industry, biotechnology. This list helps you analyze each company’s performance, income statements, and stock activity — all in one place. Sort by key metrics to find the most expensive stocks like Lonza Group AG, or spot the most traded options, such as MindMaze Therapeutics Holding SA. Ideal for investors and traders looking to build or refine a strategy within this growing tech segment.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 AMGAmgen Inc. | 174.6 B CHF | 314.214 CHF | +1.95% | 40 | 2.03 | 24.15 | 13.01 CHF | +34.18% | 2.58% | Health technology | Neutral |
 GISGilead Sciences, Inc. | 153.35 B CHF | 116.794 CHF | −1.03% | 50 | 0.33 | — | −2.15 CHF | −153.84% | 2.15% | Health technology | Buy |
 MRNA.USDModerna, Inc. | 56.71 B CHF | 160.60 USD | +15.71% | 4 | 0.00 | — | −6.45 CHF | −6.20% | 0.00% | Health technology | Neutral |
| 0QFModerna, Inc. | 56.71 B CHF | 140.859 CHF | +1.67% | 12 | 0.04 | — | −6.45 CHF | −8.21% | 0.00% | Health technology | Neutral |
 LO3Lonza Group AG | 37.4 B CHF | 555.634 CHF | +1.09% | 25 | 0.23 | — | −1.55 CHF | −115.18% | 0.92% | Health technology | Buy |
| LONNLonza Group AG | 37.4 B CHF | 555.6 CHF | +1.24% | 13.75 K | 0.08 | — | −1.55 CHF | −115.18% | 0.92% | Health technology | Buy |
 22UABioNTech SE Sponsored ADRDR | 20.22 B CHF | 78.998 CHF | −3.33% | 110 | 1.22 | — | −6.34 CHF | −399.64% | 0.00% | Health technology | Buy |
 HDP1Arrowhead Pharmaceuticals, Inc. | 7.98 B CHF | 54.361 CHF | −23.80% | 40 | — | — | −1.81 CHF | −80.90% | 0.00% | Health technology | Strong buy |
 1CGCRISPR Therapeutics AG | 4.63 B CHF | 48.641 CHF | +13.92% | 912 | 0.90 | — | −3.85 CHF | +10.55% | 0.00% | Health technology | Buy |
 VIRVir Biotechnology, Inc. | 1.51 B CHF | 8.702 CHF | −5.57% | 50 | — | — | −1.50 CHF | +52.70% | 0.00% | Health technology | Strong buy |
 PPGNPolyPeptide Group AG | 1.45 B CHF | 44.10 CHF | +0.23% | 37.71 K | 0.41 | 109.10 | 0.40 CHF | — | 0.00% | Health technology | Neutral |
| 8H0PolyPeptide Group AG | 1.45 B CHF | 44.002 CHF | +0.08% | 1.15 K | 1.34 | 108.86 | 0.40 CHF | — | 0.00% | Health technology | Neutral |
 NVV1Novavax, Inc. | 1.41 B CHF | 7.776 CHF | +4.57% | 280 | 0.37 | — | −1.23 CHF | −168.74% | 0.00% | Health technology | Buy |
 BIOVBioVersys AG | 156.02 M CHF | 26.6 CHF | −6.99% | 3.47 K | 1.24 | — | −4.51 CHF | −29.97% | 0.00% | Health technology | Strong buy |
 MOLNMolecular Partners AG | 137.27 M CHF | 3.38 CHF | −0.59% | 80 | 0.01 | — | −1.36 CHF | +24.46% | 0.00% | Health technology | Strong buy |
| 6MLMolecular Partners AG | 137.27 M CHF | 3.449 CHF | +4.42% | 11 | 0.06 | — | −1.36 CHF | +24.46% | 0.00% | Health technology | Strong buy |
 MMTXMindMaze Therapeutics Holding SA | 25.7 M CHF | 0.1456 CHF | +1.96% | 250.96 K | 0.18 | — | — | — | 0.00% | Health technology | No rating |
| MMTXMindMaze Therapeutics Holding SA | 25.7 M CHF | 0.168 CHF | +1.20% | 1.25 K | 0.40 | — | — | — | 0.00% | Health technology | No rating |